Plain-English translation of NCT06689241 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After weight loss surgery, blood clots can be a serious complication. This trial is testing whether , a pill taken by mouth, works as well as , an injection given under the skin, to prevent blood clots from forming in the weeks after your surgery.
Blood clots are the leading cause of death after people leave the hospital following weight loss surgery. Doctors want to find the safest and most convenient way to prevent them—especially for people with severe obesity, who face higher risks.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either a daily pill or daily injections for 14 days after your weight loss surgery. If you receive the pill (), you'll take it by mouth starting one day after surgery. If you receive the injection (), you'll get a shot under your skin starting 12 hours after surgery. The study follows you for 14 days to monitor your recovery and watch for any blood clots.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Egypt
Enrollment target
~162 participants
Started
October 2024
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
20 Years – 60 Years
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
sarah m elgamal, MD
Alexandria University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.